Defined dimensional alterations in enzyme substrates. Birch reduction of lin-benzopurines. A contribution to information concerning the binding sites of adenosine deaminase and xanthine oxidase
Preventives and/or remedies for Parkinson's disease and symptoms associating therewith such as anxiety, depression and/or memory disorder which contain as the active ingredient an adenosine A1A2a receptor dual antagonist or salts thereof.
Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
申请人:Fujisawa Pharmaceutical Co. Ltd.
公开号:US20040152659A1
公开(公告)日:2004-08-05
Preventives and/or remedies for Parkinson's disease and symptoms associating therewith such as anxiety, depression and/or memory disorder which contain as the active ingredient an adenosine A
1
A
2a
receptor dual antagonist or salts thereof.
帕金森病及其相关症状(如焦虑、抑郁和/或记忆障碍)的预防剂和/或治疗剂,其活性成分包含腺苷 A
1
A
2a
受体双重拮抗剂或其盐类。
LEONARD N. J.; KAZMIERCZAK F.; RYKOWSKI A., J. ORG. CHEM., 52,(1987) N 13, 2933-2935
作者:LEONARD N. J.、 KAZMIERCZAK F.、 RYKOWSKI A.
DOI:——
日期:——
LEONARD, NELSON J.;PETRIC, ANDREJ;RYKOWSKI, ANDRZEJ, J. ORG. CHEM., 53,(1988) N 16, C. 3873-3875
作者:LEONARD, NELSON J.、PETRIC, ANDREJ、RYKOWSKI, ANDRZEJ